Abstract
Unmethylated CpG dinucleotides have been found to stimulate general immune responses in mammals. CpG motifs have further been shown to be potent adjuvants when used in conjunction with vaccines for viral and bacterial organisms. It was necessary to determine whether these CpG motifs will also enhance immune responses in parasitic diseases. We therefore decided to test the effect of CpG adjuventation on immunization with a temperature-sensitive mutant (ts4) strain of Toxoplasma gondii. Mice were divided into groups receiving either ts4 only, CpG only, ts4 with CpG, or untreated controls. Mice were challenged with a lethal dose of T. gondii (RH strain) tachyzoites 28 days after vaccination. There were significant differences observed between the ts4-only group and the other three groups with regards to antibody isotype and survival, with the former group surviving lethal challenge. CpG adjuventation appeared to not enhance survival.
Similar content being viewed by others
References
Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS (1997) Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 84:185–193
Cheadle MA, Lindsay DS, Blagburn BL (1999) Prevalence of antibodies to Neospora caninum in dogs. Vet Parasitol 85:325-330
Corral RS, Petray PB (2001) CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19:234–242
Desolme B, Mevelec MN, Buzoni-Gatel D, Bout D (2000) Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18:2512–2521
Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM (1999) Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 162:2291–2298
Fachado A, Rodriguez A, Angel SO, Pinto DC, Vila I, Acosta A, Amendoeira RR, Lannes-Vieira J (2003) Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21:1327–1335
Gavrilescu LC, Denkers, EY (2001) IFN-γ overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J Immunol 167:902–909
Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A (1991) Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146:286–292
Gomis S, Babiuk L, Godson DL, Allan B, Thrush T, Townsend H, Willson P, Waters E, Hecker R, Potter A (2003) Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect Immun 71:857–863
Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL (2001) Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun 69:1643–1649
Jiang W, Baker HJ, Smith BF (2003) Mucosal immunization with Helicobacter, CpG DNA, and cholera toxin is protective. Infect Immun 71:40–46
Jones TR, Obaldia III N, Gramzinski RA, Charoenvit Y, Kolodny N, Kitov S, Davis HL, Krieg AM, Hoffman SL (1999) Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine 17:3065–3071
Khan IA, Casciotti L (1999) IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. J Immunol 163:4503–4509
Krahenbul JL, Remington JS (1982) Immunology of Toxoplasma and toxoplasmosis. In Cohen S, Warren KS (eds) Immunology of parasitic infections. Blackwell, London
Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549
Krieg AM, Love-Homan, L, Yi AK, Harty JT (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 161:2428–2434
Lee SW, Sung YC (1998) Immuno-stimulatory effects of bacterial-derived plasmids depend on the nature of the antigen in intramuscular DNA inoculations. Immunology 94:285–289
Lee Y-H, Channon JY, Matsuura T, Schwartzman JD, Shin D-W, Kasper L (1999) Functional and quantitative analysis of splenic T cell immune responses following oral Toxoplasma gondii infection in mice. Exp Parasitol 91:212–221
Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 98:1119–1129
Nielsen HV, Lauemoller SL, Christiansen L, Buus L, Fomsgaard A, Petersen E (2000) Complete protection against lethal T. gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 67:6356–6363
Sayles PC, Johnson LL (1996) Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii. Infect Immun 64:3088–3092
Sayles PC, Gibson GW, Johnson LL (2000) B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun 68:1026–1033
Spencer JA, Hill GM, Jezewski A, Young-White R, Blagburn BL (1999) The immune responses to Neospora caninum infection in BALB/c mice. Exp Biol Proc 202
Stacey KJ, Blackwell JM (1999) Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun 67:3719–3726
Waldeland H, Frenkel JK (1983) Live and killed vaccines against toxoplasmosis in mice. J Parasitol 69:60–65
Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM (1996) Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 157:5394–5402
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spencer, J.A., Smith, B.F., Guarino, A.J. et al. The use of CpG as an adjuvant to Toxoplasma gondii vaccination. Parasitol Res 92, 313–316 (2004). https://doi.org/10.1007/s00436-003-1039-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-003-1039-7